Celadon Pharmaceuticals PLC CEL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- GBX 101.50
- Day Range
- GBX 101.49–105.00
- 52-Week Range
- GBX 73.44–180.00
- Bid/Ask
- GBX 98.00 / GBX 105.00
- Market Cap
- GBX 6.74 Bil
- Volume/Avg
- 146 / 48,906
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2,589.32
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Celadon Pharmaceuticals PLC focuses on growing indoor hydroponic high-quality cannabis initially for use within the chronic pain market. It has two reportable segments Celadon is a Build of grow facilities, growing medical grade cannabis and research in the GMP lab, and Harley Street (CPC) is a clinical study into the pain relief benefits of medicinal cannabis.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- 16
- Website
- https://www.celadonpharma.co.uk
Comparables
Valuation
|
Metric
|
CEL
|
ALLFG
|
MRL
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 12.01 | 7.66 |
Price/Book Value | 43.91 | 1.56 | 1.10 |
Price/Sales | 2,589.32 | 1.32 | 0.97 |
Price/Cash Flow | — | 13.89 | 11.94 |
Price/Earnings
CEL
ALLFG
MRL
Financial Strength
|
Metric
|
CEL
|
ALLFG
|
MRL
|
|---|---|---|---|
Quick Ratio | 1.84 | 1.17 | 1.13 |
Current Ratio | 1.86 | 1.18 | 1.29 |
Interest Coverage | −1.30 | 6.36 | −0.19 |
Quick Ratio
CEL
ALLFG
MRL
Profitability
|
Metric
|
CEL
|
ALLFG
|
MRL
|
|---|---|---|---|
Return on Assets (Normalized) | −49.33% | 3.89% | 4.66% |
Return on Equity (Normalized) | −105.03% | 9.25% | 9.08% |
Return on Invested Capital (Normalized) | −24.42% | 3.60% | 7.76% |
Return on Assets
CEL
ALLFG
MRL
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Lppfjhpggc | Bkyz | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Dtxczxtry | Zmdwj | $69.1 Bil | |
HLN
| Haleon PLC ADR | Kscdqqhrx | Vrmv | $37.6 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Knyhgtdb | Xvyz | $15.6 Bil | |
VTRS
| Viatris Inc | Chnhbrx | Dytl | $13.8 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Lsgvllvhm | Wjfhw | $12.4 Bil | |
CTLT
| Catalent Inc | Ykcxmwn | Jvqxpf | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Sdqgcgjc | Mrdw | $4.5 Bil | |
CURLF
| Curaleaf Holdings Inc | Xfnjppc | Vxbnn | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Lbzmjbrt | Rjpkrg | $3.5 Bil |